लोड हो रहा है...
Biomarker development for PD-(L)1 axis inhibition: a consensus view from the SITC Biomarkers Committee
Therapies targeting the programmed cell death protein-1/programmed death-ligand 1 (PD-L1) (abbreviated as PD-(L)1) axis are a significant advancement in the treatment of many tumor types. However, many patients receiving these agents fail to respond or have an initial response followed by cancer pro...
में बचाया:
| मुख्य लेखकों: | , , , , , , , |
|---|---|
| स्वरूप: | Artigo |
| भाषा: | Inglês |
| प्रकाशित: |
BMJ Publishing Group
2024-07-01
|
| श्रृंखला: | Journal for ImmunoTherapy of Cancer |
| ऑनलाइन पहुंच: | https://jitc.bmj.com/content/12/7/e009427.full |
| टैग : |
टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!
|